Here is an article from Cardiff Uni ref stem cells

http://www.cardiff.ac.uk/research/cancerstemcell/people/prof-m-mason.html

York University ref targeting stem cells in prostate cancer

http://www.york.ac.uk/news-and-events/news/2013/research/prostate-cancer/

Some traditional biopsies for prostate cancer may be replaced by low cost ‘liquid biopsies’

http://www.medicalnewstoday.com/releases/258652.php

Research is the only route to finding a cure for prostate cancer.

We know that as prostate cancer progresses in a man that has had a diagnosis of the disease then the drugs and/or equipment to treatment them become more and more expensive.

Currently they hardly ever look for indications of prostate cancer in men under the age of 50. Even the NICE guidelines use the arbitrary (my word) 50 as the starting point looking for the disease.

Prostate Cancer can take 20-25 years growing before it becomes detectable so surely they should begin looking for indications, not conformation in young men from the age of 25.

A study that would track the health of young mens prostate gland may well give them a better indication of when things start to go wrong and perhaps indicate why and then these young men could be treated at a stage when a cure may be possible and it may reveal those men who will never need testing.

As with most prostate cancer studies it would take maybe 15 years before any meaningful results could be achieved but my view is that if you dont start you will never get to the end.

Perhaps the work currently being done by Siobhan Sutcliffe & Graham Colditz (Nature Reviews) may open a few eyes.

http://www.prostate.net/prostate-health/testosterone-hormones-and-prostate-health/what-is-testosterone/

This article by prostate.net is an easy to understand description of testosterone and what its role is in prostate cancer.

As they say this is not a substitute for medical advice or should even be taken as medical advice.

http://www.urotoday.com/Prostate-Cancer/cancer-mortality-down-20-from-1991-peak.html

http://www.medicalnewstoday.com/releases/254982.php

This study by Kaiser Permanente published in the British Journal of Urology International comes as no surprise the families who have lost the man in their lives to the most common cancer in men.

The red sock campaign along with Sian at PMG and the Blims would like to see a study done on men from the age of 30 using the PSA test to see if there are indications of when things start to go wrong. It would be a long term study as we know that prostate cancer in the early stages is a slow growing cancer BUT if whilst we sit and wait for a diagnostic tool for prostate cancer families are being torn apart by losing the man in their lives to a disease that when diagnosed early enough is almost always curable,

http://minnesota.publicradio.org/display/web/2012/12/03/health/mayo-clinic-prostate-cancer-scan/?refid=0&utm_source=twitterfeed&utm_medium=twitter&utm_campaign=Feed%3A+MPR_NewsFeatures+%28News+%26+Features+from+Minnesota+Public+Radio%29

http://prostatecancerinfolink.net/2012/11/08/psma-adc-shows-positive-results-in-phase-i-clinical-trial-in-advanced-mcrpc/

We men who have been treated for prostate cancer live waiting for the cancers recurrence.

In the UK at present it is usual to check a mans PSA level periodically and think about treatment options when his PSA level is between 20-30.

This new method which is now approved by the FDA for use in the USA  can detect recurrent prostate cancer when the PSA level has risen to 2.

From a layman’s point of view it looks like a massive step forward in treating men with prostate cancer earlier when it reacurrs and presumably it means less invasive treatment.

http://www.news-medical.net/news/20121109/Mayo-Clinic-receives-FDA-approval-for-Choline-C-11-Injection-to-help-detect-prostate-cancer.aspx